Venous Thromboembolism
📧 Sign up to get email alerts when something new happens for Venous Thromboembolism.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-11-20Clinical Trial Update: Prophylaxis of Venous Thromboembolism After Bariatric Surgery [Phase 4]
Phase 4 clinical trial update evaluating prophylaxis of venous thromboembolism after bariatric surgery. Status is UNKNOWN and no results are…
-
CLINICAL_TRIALS trial_result · 2014-11-19Clinical Trial Update: Long-term Active Surveillance Study for Oral Contraceptives (LASS)
The Long-term Active Surveillance Study (LASS) for oral contraceptives has completed, with results posted in 2014, evaluating risks of arter…
-
CLINICAL_TRIALS trial_result · 2014-10-31Clinical Trial Update: Fluorodeoxyglucose (FDG)-Positron Emission Tomography (PET) in Cancer Associated Venothromboembolism
This entry reports the completion of a trial evaluating fluorodeoxyglucose (FDG)-PET imaging in cancer-associated venous thromboembolism, sp…
-
CLINICAL_TRIALS trial_result · 2014-10-28Clinical Trial Update: Rivaroxaban (10mg) Given Once Daily in Patients Undergoing Total Hip Replacement Compared to Enoxaparin [Phase 3]
Phase 3 trial comparing rivaroxaban 10 mg once daily with enoxaparin for venous thromboembolism prevention in patients undergoing total hip …
-
CLINICAL_TRIALS trial_result · 2014-10-28Clinical Trial Update: Dose-ranging Study of Once-daily Regimen of BAY 59-7939 in the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement [Phase 2]
Phase 2 dose-ranging study evaluating once-daily BAY 59-7939 for prevention of venous thromboembolism after elective total hip replacement; …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-10-28Clinical Trial Update: Once-daily Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Deep-vein Thrombosis [Phase 2]
Phase 2 study update of BAY59-7939 (rivaroxaban), an oral direct Factor Xa inhibitor, in patients with acute symptomatic deep-vein thrombosi…
-
CLINICAL_TRIALS trial_result · 2014-10-28Clinical Trial Update: The Role of FDG-PET/CT Imaging in the Management of Patients With Thromboembolic Disorders (The PETVET Study)
The PETVET study reports on the role of FDG-PET/CT imaging in managing patients with venous thromboembolism, based on completed trial result…
-
CLINICAL_TRIALS trial_result · 2014-10-27Clinical Trial Update: Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE). A Study of BAY 59-7939 in the Prevention of VTE in Subjects Undergoing Elective Total Knee Replacement. [Phase 3]
Phase 3 study of rivaroxaban (BAY 59-7939) for prevention of venous thromboembolism in adults undergoing elective total knee replacement has…
-
CLINICAL_TRIALS research · 2014-10-15Clinical Trial Update: Oral Verses Patch Trial In Menopausal Women - Individualisation of Oestrogen Therapy [Phase 4]
This Phase 4 trial update compares oral versus patch estrogen therapy in menopausal women to tailor treatment. The study indicates condition…
-
CLINICAL_TRIALS trial_result · 2014-09-23Clinical Trial Update: Toronto Thromboprophylaxis Patient Safety Initiative [NA]
This clinical trial update summarizes the completed Toronto Thromboprophylaxis Patient Safety Initiative evaluating venous thromboembolism p…
-
CLINICAL_TRIALS trial_result · 2014-09-10Clinical Trial Update: A Comparison of Dalteparin and Tinzaparin for Prevention of Blood Clots in Hemodialysis Patients on Oral Anticoagulants Having Surgery [Phase 2, Phase 3]
Completed Phase 2/3 trial comparing dalteparin and tinzaparin for prevention of venous thromboembolism in hemodialysis patients undergoing s…
-
CLINICAL_TRIALS trial_result · 2014-09-09Clinical Trial Update: Fiix-prothrombin Time for Monitoring Warfarin [Phase 2]
Phase 2 clinical trial evaluating Fiix-prothrombin Time for monitoring Warfarin therapy has completed.
-
CLINICAL_TRIALS trial_result · 2014-09-04Clinical Trial Update: Multicenter Registry for Effectiveness Analysis of ActiveCare+S.F.T® Mobile Compression Device for Thrombosis Prevention in Hip and Knee Arthroplasty
A multicenter registry study evaluating the effectiveness of the ActiveCare+S.F.T Mobile Compression Device for preventing venous thromboemb…
-
CLINICAL_TRIALS trial_result · 2014-08-27Clinical Trial Update: Active Comparator-Controlled Study to Assess Safety and Efficacy of ISIS-FXIRx in Total Knee Arthroplasty [Phase 2]
Phase 2 active-comparator trial evaluated the safety and efficacy of ISIS-FXIRx for preventing venous thromboembolism after total knee arthr…
-
CLINICAL_TRIALS trial_result · 2014-08-13Clinical Trial Update: Self-management of Low Molecular Weight Heparin Therapy [Phase 4]
Phase 4 trial update on self-management of low molecular weight heparin therapy for venous thromboembolism; results have been posted.
-
CLINICAL_TRIALS trial_result · 2014-08-04Clinical Trial Update: A Prospective Pharmacodynamic Study of Rivaroxaban
The document reports the completion of a prospective pharmacodynamic study of rivaroxaban.
-
CLINICAL_TRIALS trial_result · 2014-06-23Clinical Trial Update: Pharmacokinetic (PK) Assessment of BIBR 1048 in Patients After Primary Elective Total Hip Replacement Surgery [Phase 2]
This update reports Phase 2 pharmacokinetic data for BIBR 1048 in patients after primary elective total hip replacement, in a trial addressi…
-
FDA approval · 2014-06-12FDA Approved: HEPARIN SODIUM — Original Application (Sandoz Inc.)
FDA approved Sandoz Inc.'s original application for generic heparin sodium, an injectable anticoagulant used to prevent and treat thrombotic…
-
CLINICAL_TRIALS trial_result · 2014-05-20Clinical Trial Update: Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness [Phase 3]
A Phase 3 study evaluating apixaban for the prevention of thrombosis-related events in patients with acute medical illness has completed and…
-
CLINICAL_TRIALS trial_result · 2014-05-05Clinical Trial Update: Venous Thromboembolism Prophylaxis in Medical and Surgical ICUs in a Single University Hospital
A clinical trial at Yonsei University evaluating venous thromboembolism prophylaxis in medical and surgical ICU patients has completed.
-
CLINICAL_TRIALS trial_result · 2014-04-29Clinical Trial Update: The Impact of Different Anticoagulant Therapy on Hemorrhage and Coagulation After Thoracic Surgery [NA]
A completed clinical trial evaluated how different anticoagulant therapies affect bleeding and coagulation after thoracic surgery.
-
CLINICAL_TRIALS trial_result · 2014-04-25Clinical Trial Update: The Clinical Utility of Thrombelastography in Guiding Prophylaxis of Venous Thromboembolism Following Trauma [NA]
Clinical trial completed evaluating thrombelastography-guided prophylaxis for venous thromboembolism after trauma; results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-04-07Clinical Trial Update: Single Intravenous Administration of TB-402 for the Prophylaxis of Venous Thromboembolic Events (VTE) After Total Knee Replacement Surgery [Phase 2]
This report notes the completion of a Phase 2 trial evaluating TB-402 for the prevention of venous thromboembolism after total knee replacem…
-
FDA approval · 2014-03-19FDA Approved: FONDAPARINUX SODIUM — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental ANDA for Fondaparinux sodium from Dr. Reddy's Laboratories Limited, authorizing the generic product to be market…
-
CLINICAL_TRIALS trial_result · 2014-03-18Clinical Trial Update: Explicit Assessment of Thromboembolic Risk and Prophylaxis for Medical Patients in Switzerland
A completed clinical trial from Switzerland assessed thromboembolic risk and the use of prophylaxis in medical patients.